Advertisement

Medicinal Chemistry Research

, Volume 28, Issue 1, pp 39–51 | Cite as

In vitro and in vivo studies of 5,7-dihydroxy flavones isolated from Alpinia galanga (L.) against human lung cancer and ascetic lymphoma

  • S. Lakshmi
  • Sandra Suresh
  • B. S. Rahul
  • R. Saikant
  • Vani Maya
  • Manoj Gopi
  • G. Padmaja
  • P. Remani
Original Research
  • 90 Downloads

Abstract

Alpinia galanga (A. galanga) of Zingiberaceae family has been widely studied for their potential biological and medicinal properties. In this study, chrysin, isolated from A. galanga, was screened for the presence of the flavonoid compound 5,7-dihydroxyflavone. Chrysin was found to induce cytotoxicity and apoptosis in human lung cancer cells and murine lymphoma cells at 25, 50, and 75 µg/ml concentrations sparing the normal fibroblast cells and lymphocytes. Cell cycle analysis using flow cytometry showed that there was a dose-dependent increase of accumulation of the S-phase cells, causing a G1/S-phase arrest induced by chrysin at these concentrations. Annexin V- and active caspase-3-positive cells were found to increase dose dependently in these cells as evidenced by flow cytometry. The ascetic tumor reduction studies in Dalton’s lymphoma ascites mice models revealed that a dose of 1.3 mg/kg body weight of chrysin decreased the tumor volume significantly and increased the lifespan of mice to 52.6%. Moreover, the compound showed chemoprotective effects when administered along with cyclophosphamide, thereby reducing the toxic effects. These observations were confirmed using the evaluations of hematological parameters and liver and kidney function tests from animal studies. The synergistic interaction of chrysin with cyclophosphamide in terms of reducing the tumor size and increasing the lifespan of mice compared with the individual treatments suggests the possibility of reducing cyclophosphamide concentrations in the combination treatment.

Keywords

Apoptosis Chemoprotection Chrysin Lung cancer Lymphoma 

Notes

Acknowledgements

We would like to acknowledge Indian Council of Medical Research (ICMR), Government of India, No. 45/31/2006/BMS/TRM for financial support. We extend our sincere thanks to Scientists and staff of Regional cancer centre (RCC) and Central tuber crops research institute (CTCRI) and HLL Lifecare Limited, Thiruvananthapuram for the support and guidance, Dr. TR Santhosh Kumar, Scientist F for flow cytometry molecular platforms at Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram and University of Kerala, Karyavattom, Thiruvananthapuram for spectral studies and Dr. K Sujathan, Associate Professor, Regional Cancer Centre, Thiruvananthapuram for histopathological studies.

Funding

The work was funded by Indian Council of Medical Research (ICMR), Government of India, Ref No. 45/31/2006/BMS/TRM.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable International, National, and Institutional guidelines for the care of animals were followed as per Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India. (Ref No: IAEC/RCC/No.1/06 dated 29.07.06).

Supplementary material

44_2018_2260_MOESM1_ESM.pdf (319 kb)
Supplementary Information

References

  1. Abel SDA, Dadhwal S, Gamble AB, Baird SK (2018) Honey reduces the metastatic characteristics of prostate cancer cell lines by promoting a loss of adhesion Peer J 6:e5115, 1–21CrossRefGoogle Scholar
  2. Gismondi A, Di MG, Canuti L, Canini A (2017) Antiradical activity of phenolic metabolites extracted from grapes of white and redVitis vinifera L. Cultivars. Vitis 56:19–26Google Scholar
  3. Al-snafi AE (2014) The pharmacological activities of Alpinia galangal—a review. IJPRS 3:607–14Google Scholar
  4. Aston WJ, Hope DE, Nowak AK, Robinson BW, Lake RA, Lesterhuis WJ (2017) A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer 17:684CrossRefGoogle Scholar
  5. Baruah MM, Sharma N, Khandwekar AP (2016) Flavonoids and prostate cancer. AIJRFANS 15:01–07Google Scholar
  6. Batra P, Sharma AK (2013) Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech 3:439–459CrossRefGoogle Scholar
  7. Bruschi ML, Franco SL, Gremiao MPD (2003) Application of an HPLC method for analysis of propolis extract. J Liq Chrom Relat Technol 26:2399–2409CrossRefGoogle Scholar
  8. Chen X, Lowe M, Herliczek T, Hall MJ, Danes C, Lawrence DA, Keyomarsi K (2000) Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G1 arrest. J Natl Cancer Inst 92:1999–2008CrossRefGoogle Scholar
  9. Ciolino HP, Yeh GC (1999) The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br J Cancer 79:1340–1346CrossRefGoogle Scholar
  10. Cooper JR, Abdullatif MB, Burnett EC, Kempsell KE, Conforti F, Tolley H, Collins JE, Davies DE (2016) Long term culture of the A549 cancer cell line promotes multilamellar body formation and differentiation towards an alveolar type II pneumocyte phenotype. PLoS ONE 11:e0164438CrossRefGoogle Scholar
  11. Crowley LC, Marfell JB, Waterhouse NJ (2016) Analyzing cell death by nuclear staining with Hoechst 33342. Cold Spring Harb Protoc  https://doi.org/10.1101/pdb.prot087205
  12. Crozier A, Jaganath IB, Clifford MN (2006) Phenols, polyphenols and tannins: an overview. In: Crozier A, Clifford MN, Ashihara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell Publishing Ltd, Oxford, pp 1–24Google Scholar
  13. DeBerardinis RJ (2008) Is cancer a disease of abnormal cellular metabolism. Genet Med 10:767–777CrossRefGoogle Scholar
  14. Falcone Ferreyra ML, Rius SP, Casati P (2012) Flavonoids: biosynthesis, biological functions and biotechnological applications. Front Plant Sci 3:1–15Google Scholar
  15. Hadjzadeh MR, Afshari JT, Barati M (2009) The inhibitory effects of ethanolic extract Alpinia galangal on colonic cancer cells (HT-29) and L929 cells in vitro. Urmia Med J 3:572–82Google Scholar
  16. Hadjzadeh MR, Ghanbari H, Keshavarzi Z, Afshari JT (2014) The effects of aqueous extract of alpinia galangal on gastric cancer cells (AGS) and L929 cells in vitro. Iran J Cancer Prev 7:142–146Google Scholar
  17. Havsteen BH (2002) The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96:67–202CrossRefGoogle Scholar
  18. Ingersoll KS, Cohen J (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 31:213–224CrossRefGoogle Scholar
  19. Jaju SB, Indurwade NH, Sakarkar DM, Fuloria NK, Ali MD, Basu SP (2010) Isolation of β-sitosteroldiglucosylcaprate from Alpinia galanga. Pharm Res 2:264–266Google Scholar
  20. Jiang H, Xie Z, Koo HJ, McLaughlin SP, Timmermann BN, Gang DR (2006) Metabolic profiling and phylogenetic analysis of medicinal Zingiber species: tools for authentication of ginger (Zingiber officinale Rosc). Phytochemistry 67:1673–85CrossRefGoogle Scholar
  21. Joy PP, Thomas J, Mathew S, Skaria BP (2002) Effect of spacing and manuring on growth, yield and nutrient content of Alpinia galanga (L.) Willd. JOSAC 11:22–253Google Scholar
  22. Kasibhatla S, Mendes GPA, Finucane D, Brunner T, Wetzel EB, Green DR (2006) Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harb Protoc  https://doi.org/10.1101/pdb.prot4493
  23. Khoo BY, Chua SL, Balram P (2010) Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci 11:2188–2199CrossRefGoogle Scholar
  24. Kim HR, Park CG, Jung JY (2014) Acacetin (5,7-dihydroxy-4′-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Int J Mol Med 33:317–24CrossRefGoogle Scholar
  25. Kumar MA, Nair M, Hema PS, Mohan J, Santhoshkumar TR (2007) Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells. Mol Carcinog 46:231–41CrossRefGoogle Scholar
  26. Kumari R, Rawat K, Kumari A, Shrivastava A (2017) Amelioration of Dalton’s lymphoma-induced angiogenesis by melatonin. Tumor Biol  https://doi.org/10.1177/1010428317705758
  27. Lakshmi S, Padmaja G, Remani P (2011) Antitumor effects of isocurcumenol isolated from Curcuma zedoaria rhizomes on human and murine cancer cells. Int J Med Chem 2011:253962Google Scholar
  28. Matsuda H, Morikawa T, Managi H, Yoshikawa M (2003) Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells. Bio Org Med Chem Lett 13:3197–202CrossRefGoogle Scholar
  29. Mazaheri M, Shahdadi V, Boron AN (2014) Molecular and biochemical effect of alcohlic extract of Alpinia galanga on rat spermatogenesis process. Iran J Reprod Med 12:765–770Google Scholar
  30. Mcllwain RD, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5:a008656Google Scholar
  31. Nanni V, Canuti L, Gismondi A, Canini A (2018) Hydroalcoholic extract of Spartium junceum L. ßowers inhibits growth and melanogenesis in B16-F10 cells by inducing senescence. Phytomedicine 46:1–10CrossRefGoogle Scholar
  32. Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2:270–278CrossRefGoogle Scholar
  33. Pasupuleti VR, Sammugam L, Ramesh N, Gan SH (2017) Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev 2017:1259510CrossRefGoogle Scholar
  34. Phan T, Yu XM, Kunnimalaiyaan M, Chen H (2011) Antiproliferative effect of chrysin on anaplastic thyroid cancer. J Surg Res 170:84–8CrossRefGoogle Scholar
  35. Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L (2014) Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. J Geriatr Oncol 5:307–314CrossRefGoogle Scholar
  36. Rasouli S, Zarghami N (2018) Synergistic growth inhibitory effects of chrysin and metformin combination on breast cancer cells through HTERT and cyclin D1 suppression. Asian Pac J Cancer Prev 19:977–982Google Scholar
  37. Sawangjaroen N, Subhadhirasakul S, Phongpaichit S, Siripanth C, Jamjaroen K, Sawangjaroen K (2005) The in vitro anti-giardial activity of extracts from plants that are used for self-medication by AIDS patients in southern Thailand. Parasitol Res 95:17–21CrossRefGoogle Scholar
  38. Samarghandian S, Afshari JT, Davoodi S (2011) Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics 66:1073–1079CrossRefGoogle Scholar
  39. Someya Y, Kobayashi A, Kubota K (2001) Isolation and identification of trans-2- and trans-3-hydroxy-1, 8-cineole glucosides from Alpinia galanga. Biosci Biotechnol Biochem 65:950–3CrossRefGoogle Scholar
  40. Sriram MI, Kanth SBM, Kalishwaralal K, Gurunathan S (2010) Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomed 5:753–762Google Scholar
  41. Verma RK, Garima M, Mishra G, Singh P, Jha KK, Khosa RL (2011) Alpinia galanga—an important medicinal plant: a review. Der Pharm Sin 2:142–154Google Scholar
  42. Verma RK, Mishra G, Singh P, Jha KK, Khosa RL (2015) Anti-diabetic activity of methanolic extract of Alpinia galanga Linn. aerial parts in streptozotocin induced diabetic rats. Ayu 36:91–95CrossRefGoogle Scholar
  43. Victorio CP (2011) Therapeutic value of the genus Alpinia, Zingiberaceae. Braz J Pharmacogn 21:194–201CrossRefGoogle Scholar
  44. Vue B, Zhang S, Chen QH (2016) Flavonoids with therapeutic potential in prostate cancer. Anti-Cancer Agents Med Chem 16:1205–1229CrossRefGoogle Scholar
  45. Xu Y, Tong Y, Ying J, Lei Z, Wan L, Zhu X, Ye F, Mao P, Wu X, Pan R, Peng B, Liu Y, Zhu J (2018) Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells. Oncol Lett 15:9117–9125Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • S. Lakshmi
    • 1
    • 2
  • Sandra Suresh
    • 3
  • B. S. Rahul
    • 2
  • R. Saikant
    • 2
  • Vani Maya
    • 2
  • Manoj Gopi
    • 4
  • G. Padmaja
    • 5
  • P. Remani
    • 1
  1. 1.Division of Cancer ResearchRegional Cancer CentreThiruvananthapuramIndia
  2. 2.Corporate R&D CentreHLL Lifecare LimitedThiruvananthapuramIndia
  3. 3.School of Bioscience and TechnologyVIT UniversityVelloreIndia
  4. 4.Division of Artificial Internal OrgansSree Chitra Tirunal Institute for Medical Sciences and TechnologyThiruvananthapuramIndia
  5. 5.Division of Crop Utilization and BiotechnologyCentral Tuber Crops Research InstituteThiruvananthapuramIndia

Personalised recommendations